Skip to main content
SpringerLink
Log in

A Historical Overview of Cardiovascular Medicine and Heart Failure

  • Chapter
  • First Online:
Congestive Heart Failure and Cardiac Transplantation

  • 3324 Accesses

Abstract

Judging by artifacts ranging from writings on papyrus to cave etchings and paintings from the Paleolithic Era, it is clear that the heart has always been a source of fascination, speculation, and reverence for its importance to human life. Theories and knowledge of the circulatory system evolved from the time of Aristotle and Hippocrates to Galen, Erasistratus, al-Nafis, Colombo, Harvey, and other physicians, anatomists, and professors. Even Leonardo da Vinci is recognized for his knowledge of the heart’s features and function. This chapter provides a historical perspective, observations, and theories from multiple cultures about the process of cardiovascular circulation. This progression of thought and research has laid the groundwork for and is similar to the continuing developments in therapies to treat cardiovascular problems, including heart failure.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Amidon S, Amidon T. The sublime engine: a biography of the human heart. New York, NY: Rodale Books; 2011. Introduction.

    Google Scholar 

  2. von Petzinger G, Nowell A. A place in time: situating Chauvet within the long chronology of symbolic behavioral development. J Hum Evol. 2014;74:37–54. See also, www.hominides.com/html/art/geometric-signs-prehistory.php.

    Article  Google Scholar 

  3. Reeves C. Egyptian medicine. Buckinghamshire: Shire Publications; 1992. p. 52–3.

    Google Scholar 

  4. Harris CRS. The heart and vascular system in ancient Greek medicine, from Alcmaeon to Galen. Oxford: Clarendon; 1973.

    Google Scholar 

  5. Homer. The iliad. Lattimore R, trans. Chicago, IL: University of Chicago Press; 1951. p. 283.

    Google Scholar 

  6. Vierordt H. Geschichte der Herzkrankheiten [History of heart disease – CORRECT?]. In: Puschmann T, author. Handbuch der Geschichte der Medizin. Herausgegeben von [Edited by] Max Neuburger und Julius Pagel, Jena, Gustave Fischer; 1903. p. 631.

    Google Scholar 

  7. Galen on the usefulness of the parts of the body. May MT, trans. Ithaca, NY: Cornell University Press; 1968.

    Google Scholar 

  8. Aird WC. Discovery of the cardiovascular system: from Galen to William Harvey. J Thromb Haemost. 2011;9 Suppl 1:118–29.

    Article  PubMed  Google Scholar 

  9. Clarke CC. Henri de Mondeville. Yale J Biol Med. 1931;3(6):458–81.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. von Staden H. Physis and techne in Greek medicine. In: Bensaude-Vincent B, Newman WR, eds. The artificial and the natural: an evolving polarity. Cambridge, MA: MIT Press; 2007. p. 40.

    Google Scholar 

  11. Christie RV. Galen on Erasistratus. Perspect Biol Med. 1987;30(3):440–9.

    Article  CAS  PubMed  Google Scholar 

  12. Megill M. Heart failure. Dartmouth Med. 2000;25(1):34–7. Available from: http://dartmed.dartmouth.edu/fall00/pdf/Heart_Failure.pdf.

    Google Scholar 

  13. Castiglioni A. A history of medicine. Krumbhaar B, trans-ed. New York, NY: Alfred A Knopf; 1947. p. 317.

    Google Scholar 

  14. Sooke, A. Leonardo da Vinci’s groundbreaking anatomical sketches [Internet]. 2014 Oct 21 [cited 2016 Feb 9]. Available from: www.bbc.com/culture/story/20130828-leonardo-da-vinci-the-anatomist.

  15. Vesalius A. De Fabrica (1543; 1555). In: Debus AG, trans. Man and nature in the Renaissance. Cambridge: Cambridge University Press; 1978.

    Google Scholar 

  16. Loukas M, Lam R, Tubbs RS, Shoja MM, Apaydin N. Ibn al-Nafis (1210-1288): the first description of the pulmonary circulation. Am Surg. 2008;74(5):440–2.

    PubMed  Google Scholar 

  17. Wilson LG. The problem of the discovery of the pulmonary circulation. J Hist Med Allied Sci. 1962;17:229–44.

    Article  CAS  PubMed  Google Scholar 

  18. Whitteridge G. William Harvey and the circulation of the blood. New York, NY: American Elsevier, Inc.; 1971.

    Google Scholar 

  19. Pagel W. The ‘claim’ of Cesalpino and the first and second editions of his “Peripatetic Questions”. Hist Sci. 1975;13(2):130–8.

    Article  CAS  PubMed  Google Scholar 

  20. Prioreschi P. Andrea Cesalpino and systemic circulation. Ann Pharm Fr. 2004;62(6):382–400. Article in French.

    Article  CAS  PubMed  Google Scholar 

  21. Eknoyan G, De Santo NG. Realdo Colombo (1516-1559). A reappraisal. Am J Nephrol. 1997;17(3-4):261–8.

    Article  CAS  PubMed  Google Scholar 

  22. Realdi Columbi Cremonesis. De re anatomic libri XV. Venetiis: Ex Typographia Nicolai Beuilacquae; 1559.

    Google Scholar 

  23. Meyerhof M. Ibn An-Nafis (XIIIth Cent.) and his theory of the lesser circulation. Isis. 1935;23:100–20.

    Article  Google Scholar 

  24. Temkin O. Was Servetus influenced by Ibn An-Nafis? Bull Hist Med. 1940;8:731–4.

    Google Scholar 

  25. Arcieri GP. The circulation of the blood and Andrea Cesalpino of Arezzo. New York, NY: S.F. Vanni; 1945. p. 27.

    Google Scholar 

  26. Poynter FNL, Keeler KD. A short history of medicine. London: Mills and Boon; 1961. p. 34.

    Google Scholar 

  27. Castiglioni A. A history of medicine. Krumbhaar B, trans-ed. New York, NY: Alfred A Knopf; 1947. p. 519.

    Google Scholar 

  28. Ventura HO, Mehra MR. Bloodletting as a cure for dropsy: heart failure down the ages. J Card Fail. 2005;11(4):247–52.

    Article  PubMed  Google Scholar 

  29. Katz AM. The ‘modern’ view of heart failure: how did we get here? Circ Heart Fail. 2008;1(1):63–71.

    Article  CAS  PubMed  Google Scholar 

  30. Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, Dunkman WB, Jacobs W, Francis GS, Florh KH, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med. 1986;314(24):1547–52.

    Article  CAS  PubMed  Google Scholar 

  31. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311(13):819–23.

    Article  CAS  PubMed  Google Scholar 

  32. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med. 1982;307(4):205–11.

    Article  CAS  PubMed  Google Scholar 

  33. Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, Smith R, Dunkman WB, Loeb H, Wong M, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991;325(5):303–10.

    Article  CAS  PubMed  Google Scholar 

  34. Cohn JN, Tognoni G, Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker Valsartan in chronic heart failure. N Engl J Med. 2001;345(23):1667–75.

    Article  CAS  PubMed  Google Scholar 

  35. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med. 1991;325(5):293–302.

    Google Scholar 

  36. Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA. 1995;273(18):1450–6.

    Article  CAS  PubMed  Google Scholar 

  37. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353(9169):2001–7.

    Google Scholar 

  38. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 1996;334(21):1349–55.

    Article  CAS  PubMed  Google Scholar 

  39. Doughty RN, Whalley GA, Gamble G, MacMahon S, Sharpe N. Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. J Am Coll Cardiol. 1997;29(5):1060–6.

    Article  CAS  PubMed  Google Scholar 

  40. Konstam MA, Rousseau MF, Kronenberg MW, Udelson JE, Melin J, Stewart D, Dolan N, Edens TR, Ahn S, Kinan D, et al. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators. Circulation. 1992;86(2):431–8.

    Article  CAS  PubMed  Google Scholar 

  41. Konstam MA, Kronenberg MW, Rousseau MF, Udelson JE, Melin J, Stewart D, Dolan N, Edens TR, Ahn S, Kinan D, et al. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators. Circulation. 1993;88(5 Pt 1):2277–83.

    Article  CAS  PubMed  Google Scholar 

  42. Greenberg B, Quinones MA, Koilpillai C, Limacher M, Shindler D, Benedict C, Shelton B. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy. Circulation. 1995;91(10):2573–81.

    Article  CAS  PubMed  Google Scholar 

  43. Swedberg K. History of beta blockers in congestive heart failure. Heart. 1998;79 Suppl 2:S29–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Gheorghiade M, Colucci WS, Swedberg K. Beta-blockers in chronic heart failure. Circulation. 2003;107(12):1570–5.

    Article  PubMed  Google Scholar 

  45. Taylor AL, Ziesche S, Yancy C, Carson P, D’Agostino Jr R, Ferdinand K, Taylor M, Adams K, Sabolinski M, Worcel M, Cohn JN, African-American Heart Failure Trial Investigators. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med. 2004;351(20):2049–57.

    Article  CAS  PubMed  Google Scholar 

  46. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341(10):709–17.

    Article  CAS  PubMed  Google Scholar 

  47. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003;348(14):1309–21.

    Article  CAS  PubMed  Google Scholar 

  48. Missov E, Mair J. A novel biochemical approach to congestive heart failure: cardiac troponin T. Am Heart J. 1999;138(1 Pt 1):95–9.

    Article  CAS  PubMed  Google Scholar 

  49. Missov ED, De Marco T. Clinical insights on the use of highly sensitive cardiac troponin assays. Clin Chim Acta. 1999;284(2):175–85.

    Article  CAS  PubMed  Google Scholar 

  50. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes 3rd NA, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W, MADIT-CRT Trial Investigators. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009;361(14):1329–38.

    Article  PubMed  Google Scholar 

  51. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH, Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352(3):225–37. Erratum in: N Engl J Med. 2005 May 19;352(20):2146.

    Article  CAS  PubMed  Google Scholar 

  52. Zareba W, Piotrowicz K, McNitt S, Moss AJ, MADIT II Investigators. Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population). Am J Cardiol. 2005;95(12):1487–91.

    Article  PubMed  Google Scholar 

  53. Hurst JW, Morris DC, Alexander RW. The use of the New York Heart Association’s classification of cardiovascular disease as part of the patient’s complete Problem List. Clin Cardiol. 1999;22(6):385–90.

    Article  CAS  PubMed  Google Scholar 

  54. Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, Anand I, Maggioni A, Burton P, Sullivan MD, Pitt B, Poole-Wilson PA, Mann DL, Packer M. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation. 2006;113(11):1424–33.

    Article  PubMed  Google Scholar 

  55. Mozaffarian D, Anker SD, Anand I, Linker DT, Sullivan MD, Cleland JG, Carson PE, Maggioni AP, Mann DL, Pitt B, Poole-Wilson PA, Levy WC. Prediction of mode of death in heart failure: the Seattle Heart Failure Model. Circulation. 2007;116(4):392–8.

    Article  PubMed  Google Scholar 

  56. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971;285(26):1441–6.

    Article  CAS  PubMed  Google Scholar 

  57. Rector TS, Tschumperlin LK, Kubo SH, Bank AJ, Francis GS, McDonald KM, Keeler CA, Silver MA. Use of the Living With Heart Failure questionnaire to ascertain patients’ perspectives on improvement in quality of life versus risk of drug-induced death. J Card Fail. 1995;1(3):201–6.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Lillehei Heart Institute, University of Minnesota, 2231, 6th Street SE, Cancer and Cardiovascular Research Building, Minneapolis, MN, 55455, USA

    Cyprian V. Weaver PhD

  2. Lillehei Heart Institute, Department of Medicine, University of Minnesota Medical Center, University of Minnesota, 2231, 6th Street SE, 4-146 Cancer and Cardiovascular Research Building, Minneapolis, MN, 55455, USA

    Daniel J. Garry MD, PhD

Authors
  1. Cyprian V. Weaver PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel J. Garry MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel J. Garry MD, PhD .

Editor information

Editors and Affiliations

  1. Lillehei Heart Institute, Department of Medicine, University of Minnesota Medical Center, University of Minnesota, Minneapolis, Minnesota, USA

    Daniel J. Garry

  2. Division of Cardiovascular Medicine, University of Minnesota, Minneapolis, Minnesota, USA

    Robert F. Wilson

  3. Division of Cardiovascular Medicine, University of Minnesota, Minneapolis, Minnesota, USA

    Zeev Vlodaver

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Weaver, C.V., Garry, D.J. (2017). A Historical Overview of Cardiovascular Medicine and Heart Failure. In: Garry, D., Wilson, R., Vlodaver, Z. (eds) Congestive Heart Failure and Cardiac Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-319-44577-9_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-44577-9_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-44575-5

  • Online ISBN: 978-3-319-44577-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation